News We’re Watching: UK Software Guidance, FDA Approvals, Halyard Mask Warning

Abbott landed a surprise US FDA approval for the FreeStyle Libre 3 glucose monitoring system. Also this week: updated guidance documents on software (UK) and angioplasty catheters (US), FDA clearances for Candesant and Moximed, new regulatory requirements for spinal spheres, and a warning on Halyard masks. 

"News We're Watching" Feature Image
• Source: Medtech Insight

The US Food and Drug Administration has approved a new standalone reader device for Abbott’s FreeStyle Libre 3 integrated glucose monitoring system, the company announced on 14 April.

The FreeStyle Libre 3 reader offers an alternative to the FreeStyle Libre smartphone app. It connects to the sensor on...

More from Regulation

More from Policy & Regulation